Tempest Therapeutics, Inc.

SOUTH SAN FRANCISCO, CA How do I update this listing?

Tempest Therapeutics is based out of South San Francisco. OvaScience, Inc., a life science company, focuses on the discovery, development, and commercialization of proprietary products to improve the treatment of female infertility. The company���s patented technology is based on the discovery of egg precursor cells, which are found in the ovaries.Whalewisdom has at least 154 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-03-28. The notice included securities offered of Equity

Create Alert

Contact Info

tempest therapeutics, inc.
7000 SHORELINE COURT
SOUTH SAN FRANCISCO CA    94080

Business Phone: 415-798-8589
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2013-03-28 D BIOTECHNOLOGY Equity 34,999,920 34,999,920 0
2012-08-14 D/A BIOTECHNOLOGY Equity 4,936,547 4,936,547 0
2012-08-03 D/A BIOTECHNOLOGY Equity 4,077,409 4,077,409 0
2012-07-20 D/A BIOTECHNOLOGY Equity 3,635,946 3,635,946 0
2012-07-05 D BIOTECHNOLOGY Equity 1,403,622 1,403,622 0
2012-04-09 D BIOTECHNOLOGY Equity 37,238,097 37,238,097 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALISON LAWTON subscription required
    EXECUTIVE OFFICER
CHRISTOPH WESTPHAL subscription required
    DIRECTOR
CHRISTOPHER A. BLECK subscription required
    EXECUTIVE OFFICER
HARALD STOCK subscription required
    DIRECTOR
JEFF CAPELLO subscription required
    DIRECTOR
JOHN SIMON subscription required
    DIRECTOR
JONATHAN TILLY subscription required
    DIRECTOR
MICHAEL FLANAGAN subscription required
    EXECUTIVE OFFICER
MICHELLE DIPP subscription required
    EXECUTIVE OFFICER DIRECTOR
RICHARD ALDRICH subscription required
    DIRECTOR
SCOTT CHAPPEL subscription required
    EXECUTIVE OFFICER
STEPHEN KRAUS subscription required
    DIRECTOR
THOMAS MALLEY subscription required
    DIRECTOR

Elevate your investments